Feedback Share Price (FDBK)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Feedback Plc	LSE:FDBK	London	Ordinary Share	GB0003340550	ORD 0.25P

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	+0.00p	+0.00%	2.25p	100,000	05:31:08

Bid Price		Offer Price	High Price	Low Price	Open Price
2.10p		2.40p	2.25p	2.25p	2.25p

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Electronic & Electrical Equipment	0.47	-0.30	-0.11		6.3

Related Shares
Halma (HLMA), Renishaw (RSW), Sabien Technology (SNT), Flowgroup Plc (FLOW)

Feedback (FDBK) Latest News

Feedback News

Date	Time	Source	Headline
06/7/2018	07:00	UKREG	Feedback PLC Joint broker update
29/6/2018	15:20	UKREG	Feedback PLC Director/PDMR Shareholding
27/6/2018	07:00	UKREG	Feedback PLC Grant of Options and Director/PDMR Dealing
22/6/2018	14:10	UKREG	Feedback PLC Result of General Meeting
08/6/2018	10:36	UKREG	Feedback PLC Holding(s) in Company
07/6/2018	13:07	ALNC	Feedback Shares Drop After It Reveals New Growth Strategy
07/6/2018	08:00	ALNCF	Alliance News Flash Headline
07/6/2018	07:05	UKREG	Feedback PLC Notice of General Meeting
07/6/2018	07:00	UKREG	Feedback PLC Revised strategy to build a global company
01/6/2018	09:34	ALNC	Feedback Appoints Healthcare UK Medical Director To Lead Subsidiary

More Feedback News

Feedback Takeover Rumours

Feedback (FDBK) Share Charts

1 Year Feedback Chart

1 Month Feedback Chart

Intraday Feedback Chart

Feedback (FDBK) Discussions and Chat

Feedback Forums and Chat

Date	Time	Title	Posts
17/7/2018	21:24	**Feedback PLC**	2,121
03/2/2010	11:50	Feedback looks interesting - could easily be a ten bagger over next year	396
03/9/2002	11:53	ainsley long .........................quick shart it	2
21/3/2002	17:36	FEEDBACK+1.5p -GOOD VOLUME-Reversing trend	10

Add a New Thread

Feedback (FDBK) Most Recent Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type
2018-07-17 08:57:47	2.28	100,000	2,280.00	O

View all Feedback trades in real-time

Feedback (FDBK) Top Chat Posts

Date	Subject
17/7/2018 09:20	Feedback Daily Update: Feedback Plc is listed in the Electronic & Electrical Equipment sector of the London Stock Exchange with ticker FDBK. The last closing price for Feedback was 2.25p. Feedback Plc has a 4 week average price of 1.65p and a 12 week average price of 1.65p. The 1 year high share price is 3.58p while the 1 year low share price is currently 1.20p. There are currently 281,616,584 shares in issue and the average daily traded volume is 178,974 shares. The market capitalisation of Feedback Plc is £6,336,373.14. Read Full Thread Reply
20/6/2018 19:48	lr2: Yes, I'm OK. Angry about the probable botched placing but have no problems with the quality of TexRAD. Funny how it took 12 months for Trevor Brown to collapse the share price but only 2 weeks for the BoD to do much the same. Hopefully they can regain some shareholder trust before too long. Read Full Thread Follow Reply
18/6/2018 14:13	ashtree2: Bot..thanks for that.The effect on the share price has possibly been worse than if there had been a placing at a significant discount.I would hate to think that this was done on purpose? Read Full Thread Follow Reply
14/6/2018 16:03	lr2: I believe the people who gained shares in the last placing are primarily the sellers now as they can likely bank a profit and load up again at the new placing price which looks an odds on certainty to be below 2p by a fair margin. I'm not at all happy with the BoD right now, they had the opportunity to issue a further 46,938,800 under the existing right to issue shares even without contemplating a rights issue to existing shareholders. No warning RNS needed so no wholesale price destruction either. The share price on the day before the General Meeting RNS was 2.8p. If they had issued then, even at a highly discounted 2.5p they would have raised £1.17 million. Let's see what gets raised next time around. The price they raise at is likely to be 1.75p at the rate this share is falling, maybe less. At 1.75p, they will need to use 67,055,430 to achieve the same result. That almost 21 million more shares for no more money. To save themselves from looking like prize pumpkins I would suggest the board will offer even more shares as a saving face exercise. If the board are active investors in this new placing then it looks just a little bit like trading on inside knowledge to me. Time will tell how close I am to being correct. Read Full Thread Follow Reply
13/6/2018 11:49	lr2: Yes, but by indicating another money raising they've made it a lot harder for the share price in the short term. I don't blame the board as much as I do Trevor Brown. He decimated the share price by his pernicious selling over the previous 12 months. The board opted to raise a minimal amount at the very low price caused by Trevor Brown but they could have raised some more money (they still had the authority to do so) without calling for a special meeting. That is where, perhaps, they went wrong. Once the market was forewarned of a another likely raising lots of people sold up and pushed the share price downwards. And that is why the share price is where it is. When the clinical version of TexRAD sees light of day, that's when the share price lifts off. Read Full Thread Follow Reply
12/6/2018 14:20	soundmanshane: Lots of big moves today pushes share price down ? Read Full Thread Follow Reply
27/5/2018 07:39	hughmar: What impact do you think Physiomics plc will have on the share price of Feedback if any? Physiomics plc launch 31st May 2018 doing similar work Physiomics' Virtual Tumour is a sophisticated computer model that simulates tumour cell division and predicts the effect of different anti-cancer regimes to support pre-clinical and clinical oncology development programs. Virtual Tumour helps customers to balance efficacy and toxicity and to prioritise the most effective drug combinations while reducing time and cost. Read Full Thread Follow Reply
25/5/2018 11:30	lr2: Agree Brook, if the new guy is willing to pay 3.5p then the share price has plenty of road still to travel. Read Full Thread Follow Reply
25/5/2018 11:24	lr2: Well, I hope you enjoy the ride. I've been here awhile now and have no intention of leaving until the share price is significantly higher. I reckon there is so much more to come. Read Full Thread Follow Reply
30/4/2018 17:26	tidy 2: SMALL CAP SHARE IDEAS: Heavyweight connections point way forward for medical imaging firm FeedbackGaneshan, who heads the company's medical imaging arm, carried out a study of patients with liver cancer using TexRAD, but impressed by the results Riddell saw wider scale potential.'It quickly dawned on me that this could be a really valuable objective tool for giving an accurate prognosis.'It is in lung cancer that Feedback is now starting to make serious headway.Riddell took over the chair two years ago, but crucial to the recent change of tempo was the award of the European standard CE mark for TexRAD Lung as a diagnosis tool in November.The CE mark means TexRAD Lung can now be sold to hospitals, where it will give numerical support to the work carried out by radiologists.A new chief executive, David Crabb, a software specialist, was recruited in February to spearhead the sales drive for TexRAD.Meanwhile, a tie-up with a company in Poland called Future Processing provides Feedback with the coding know-how to develop a wider product suite.Riddell says the ambition is to move from a company growing modestly to one that will be 'significantly growing'.Feedback's TexRAD texture analysis software can now be sold to hospitals, where it will give numerical support to the work carried out by radiologistsFeedback's TexRAD texture analysis software can now be sold to hospitals, where it will give numerical support to the work carried out by radiologistsSales in the half-year to November were just £229,000 while losses rose to £337,000, so there is plenty to go for.Before the award of the CE mark, the target market was individual research hospitals, now Feedback is going for distribution deals (such as the GEHC one) and major manufacturers such as Philips and Siemens.The 40 per cent jump in the share price on the GE deal news highlights the potential if more deals can be agreed.At 2.75p, Feedback is valued at just £7million and for a company with a CE Mark/European approval for lung cancer imaging it is a modest valuation, especially with the development of new treatments for the disease.As Riddell says: 'That's maybe one of the reasons Simon [Sturge] joined the board.'Feedback also has another product in its stable: an imaging archiving system Cadran that was pioneered by the Royal Papworth Hospital.Papworth has just signed a contract for another two years but Riddell believes there is scope to push Cadran out to a much larger audience.Cadran is not subject to the same regulatory regime as TexRAD, but is a vital part of medical imaging, allowing scans to be easily stored, retrieved and analysed to help diagnosis.Slow burn is probably a fair way to describe the company's progress so far even if the technology is impressive.Undoubtedly given its modest size there's an element of risk attached for investors but Riddell is confident Feedback is starting to move forward.'We have a strong board, good products and there is a huge opportunity to take advantage of our connections in the industry.'In TexRAD and Cadran we have a couple of hidden gems, now we have to burnish them and show them to the world.' Read Full Thread Follow Reply
27/2/2018 17:54	lr2: Revenue for the half year was £229k but expectation for 2nd half of year is better so perhaps they will manage £500k+ for full year. Not enough to go without more financing but perhaps not a placing with the share price so weak. Some form of short term bank financing might be considered if share price remains weak and clinical sales come in soon. Whilst a placing is always likely it is not the only option. Probably won't have long to wait to find out the answer as to which way they will go. Read Full Thread Follow Reply

Feedback share price data is direct from the London Stock Exchange

add chat code

Your Recent History

LSE

GKP

Gulf Keyst..

LSE

QPP

Quindell

FTSE

UKX

FTSE 100

LSE

IOF

Iofina

GBPUSD

UK Sterlin..

Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US Finance Manila

P:41 V: D:20180718 01:04:08